Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
13
Number of overlapping holdings
56.5%
% of XDNA's 23 holdings also in GNOM
31.7%
% of GNOM's 41 holdings also in XDNA
Overlap by Weight
Sector Drift (XDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XDNA |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
CRISPR THERAPEUTICS AG | 15.1% | 4.8% | 4.8% |
|
BEAM THERAPEUTICS, INC. | 13.7% | 3.1% | 3.1% |
|
INTELLIA THERAPEUTICS, INC. | 8.7% | 3.0% | 3.0% |
|
AGILENT TECHNOLOGIES INC | 2.7% | 4.4% | 2.7% |
|
VERTEX PHARMACEUTICALS INC | 1.5% | 1.9% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to GNOM
|
BEAM THERAPEUTICS, INC. | 10.6% |
|
CRISPR THERAPEUTICS AG | 10.3% |
|
THERMO FISHER SCIENTIFIC INC | 9.5% |
|
PRIME MEDICINE, INC. | 5.9% |
|
INTELLIA THERAPEUTICS, INC. | 5.7% |
|
EDITAS MEDICINE, INC. | 4.8% |
|
CARIBOU BIOSCIENCES, INC. | 4.1% |
|
VERVE THERAPEUTICS, INC. | 4.0% |
|
POSEIDA THERAPEUTICS, INC. | 3.8% |
|
ABBVIE INC | 3.8% |
XDNA Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -7.7% |
|
NATERA INC | -7.3% |
|
MODERNA, INC. | -4.5% |
|
ULTRAGENYX PHARMACEUTICAL IN | -4.4% |
|
BIOMARIN PHARMACEUTICAL INC | -3.7% |
|
SAREPTA THERAPEUTICS INC | -3.7% |
|
BIO-TECHNE CORPORATION | -3.5% |
|
ROCKET PHARMACEUTICALS, INC. | -3.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.2% |
 |
BIONTECH SE SPONSORED ADR | -3.1% |